Immunologic defects and vaccination in patients with chronic renal failure

Infectious Disease Clinics of North America

Volumn 15, Issue 3, 2001, Pages 813-832

  Pesanti, Edward L ^b  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE;

ANTIGEN PRESENTATION; CHRONIC KIDNEY FAILURE; DENDRITIC CELL; DIALYSIS; GLOMERULUS; HOST RESISTANCE; HUMAN; IMMUNE DEFICIENCY; INFECTION; INFECTION RESISTANCE; KIDNEY TRANSPLANTATION; LYMPHOCYTE; MACROPHAGE FUNCTION; MORTALITY; NEUTROPHIL; REVIEW; UREMIA;

EID: 0034850262     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5520(05)70174-4     Document Type: Article

References (143)

1. Essential components of a tuberculosis prevention and control program screening for tuberculosis and tuberculosis infection in high-risk populations
2. Comparison of two schedules of hepatitis B vaccination in patients with mild, moderate and severe renal failure
3. Tuberculosis in chronic renal failure in Jeddah
4. Causes of hemodialysis access failure
5. Granulocyte-macrophage colony-stimulating factor as an adjuvant to hepatitis B vaccination in maintenance hemodialysis patients
6. Adequate seroresponse to influenza vaccination in dialysis patients
7. Over a decade of experience with a yeast recombinant hepatitis B vaccine
8. Antigen-presenting cells. Experimental and clinical studies of dendritic cells
9. An indistinct balance: The safety and efficacy of parenteral iron therapy
10. Effect of chronic human recombinant erythropoietin therapy on antibody responses to immunization in chronic hemodialysis patients
11. Long-term immunogenicity and efficacy of hepatitis B vaccine in hemodialysis patients
12. Varicella vaccine in renal failure
13. HLA genetic heterogeneity of hepatitis B vaccine response in hemodialyzed patients
14. Neutrophil apoptosis and dysfunction in uremia
15. Recommendations of the Advisory Committee on Immunization Practices (ACIP): Use of vaccines and immune globulins in persons with altered immunocompetence
16. Intracutaneous versus intramuscular hepatitis B vaccination in primary non-responding haemodialysis patients
17. Hepatitis B vaccine in hemodialysis patients with hepatitis C viral infection
18. Immune dysfunction in uremia
19. Isolation of modified ubiquitin as a neutrophil chemotaxis inhibitor from uremic patients
20. Prolonged survival of skin homografts in uremic patients
21. Vaccine-associated paralytic poliomyelitis: A retrospective cohort study of acute flaccid paralyses in Brazil
22. Neutrophil beta(2)-microglobulin and lactoferrin content in renal failure patients
23. T cells and B cells in chronic renal failure
24. The immune system in end-stage renal disease
25. Cellulose carbamates and derivatives as hemocompatible membrane materials for hemodialysis
26. Effect of dialyser composition and reuse on neutrophil count and elastase alpha- 1 proteinase inhibitor complex formation
27. Hepatitis B vaccination and booster in predialysis patients: A 4-year analysis
28. Hepatitis B vaccination and interleukin 2 receptor expression in chronic renal failure
29. Epidemic transmission of human immunodeficiency virus in renal dialysis centers in Egypt
30. The safety and efficacy of GM-CSF as an adjuvant in hepatitis B vaccination of chronic hemodialysis patients who have failed primary vaccination
31. Intradermal versus intramuscular hepatitis b re-vaccination in non-responsive chronic dialysis patients: A prospective randomized study with cost-effectiveness evaluation
32. Hepatitis B virus infection in dialysis patients
33. Response to the hepatitis B virus vaccine in haemodialysis patients: Influence of malnutrition and its importance as a risk factor for morbidity and mortality
34. Immunization guidelines for pediatric renal disease
35. Poor response to a recombinant hepatitis B vaccine in dialysis patients
36. Response to early measles-mumps-rubella vaccination in infants with chronic renal failure and/or receiving peritoneal dialysis
37. Pneumococcal vaccine in children and young adults with chronic renal disease
38. Platelet-leukocyte aggregates during hemodialysis: Effect of membrane type
39. Active immunization against hepatitis B infection of a haemodialysis population
40. Production of interleukin-6, tumor necrosis factor alpha and interleukin-10 in vitro correlates with the clinical immune defect in chronic hemodialysis patients
41. Prospective crossover trial of the influence of vitamin E-coated dialyzer membranes on T-cell activation and cytokine induction
42. Host defenses and immunologic alterations associated with chronic hemodialysis
43. Outbreaks of hepatitis B virus infection among hemodialysis patients - California, Nebraska, and Texas, 1994
44. Influenza vaccination on renal transplant patients is safe and serologically effective
45. Hemodialysis-induced degranulation of polymorphonuclear cells: No correlation between membrane markers and degranulation products
46. Metabolic response of neutrophils to uremia and dialysis
47. Dysfunction of polymorphonuclear leukocytes in uremia
48. Are granulocyte inhibitory proteins contributing to enhanced susceptibility to infections in uraemia?
49. Reversal of skin test anergy during maintenance hemodialysis by protein and calorie supplementation
50. Distribution of CD4+ T lymphocytes at diagnosis of acquired immunodeficiency syndrome-defining and other human immunodeficiency virus-related illnesses
51. Patients surviving more than 10 years on haemodialysis. The natural history of the complications of treatment
52. Clinical experience with a new recombinant hepatitis-B vaccine in previous non-responders with chronic renal insufficiency
53. Approach to immunization in the immunosuppressed host
54. Biocompatibility and risk of infection in haemodialysis patients
55. Inhibition of neutrophil superoxide production by uremic concentrations of guanidino compounds
56. Immune status of children on continuous ambulatory peritoneal dialysis
57. A comparison of three brands of polysulfone membranes
58. Biocompatibility of membranes used in the treatment of renal failure
59. Neutrophil function and infections in uremia
60. Prevalence of pulmonary tuberculosis in end-stage renal disease (ESRD) patients is not unusually high
61. Hemodialysis neutropenia correlates with a decreased filterability and an increase in the number of cytoplasmic actin filaments in peripheral blood neutrophils, which is preceded by a decrease in the number of surface expression of L-selectin
62. Modulation of neutrophil apoptosis by uremic plasma during hemodialysis
63. Impact of dialyzer membrane selection on cellular responses in acute renal failure: A crossover study
64. The use of vaccines in renal failure
65. Improved vaccination response during ranitidine treatment, and increased plasma histamine concentrations, in patients with B cell chronic lymphocytic leukemia
66. Granulocyte-macrophage colony-stimulating factor enhances the efficacy of hepatitis B virus vaccine in previously unvaccinated haemodialysis patients
67. Long-term complications of dialysis: Infection
68. Frequency of complications with prolonged femoral vein catheterization for hemodialysis access
69. Transplantation, not dialysis, corrects azotemia-dependent priming of the neutrophil oxidative burst
70. Serum antibodies before and after immunisation in haemodialysed children
71. Influence of some immune factors on the IL-6 and soluble IL- 2 receptors in haemodialysed patients
72. Low efficiency of active immunization against diphtheria in chronic hemodialysis patients
73. Defective immune response to tetanus toxoid in hemodialysis patients and its association with diphtheria vaccination
74. Immune response after hepatitis A vaccination in haemodialysis patients: Comparison with hepatitis B vaccination
75. Normal response to anti-HBV vaccination in children with chronic renal insufficiency
76. Revaccination of renal transplant and hemodialysis recipients with pneumococcal vaccine
77. Cancer in patients on dialysis for end-stage renal disease: An international collaborative study
78. Hepatitis B virus infection in chronic uremia: Long-term follow-up of a two-step integrated protocol of vaccination
79. Role of haemodialysis and hepatitis C virus infection in spontaneous and induced cytokine production of patients with chronic renal disease
80. Effect of uremia and dialysis modality on mononuclear cell apoptosis
81. An investigation of circulating and in situ lymphocyte subsets and Langerhans cells in the skin and cervix of patients with chronic renal failure
82. Azotemia, TNF alpha, and LPS prime the human neutrophil oxidative burst by distinct mechanisms
83. One year immunological evaluation of chronic hemodialysis in end-stage renal disease patients
84. Low-dose intradermal versus intramuscular hepatitis B vaccination in patients with end-stage renal failure. A preliminary study
85. Selective blockade of the antigen-receptor-mediated pathway of T cell activation in patients with impaired primary immune responses
86. Vitamin D-mediated gene regulation in phenotypically defined human B cell subpopulations
87. Is dialysis membrane type responsible for increased circulating adhesion molecules during chronic hemodialysis?
88. Complications in blood access for hemodialysis
89. Hepatitis C virus infection decreases the effective antibody response to hepatitis B vaccine in hemodialysis patients
90. Antibody level after hepatitis B vaccination in hemodialysis patients: Influence of hepatitis C virus infection
91. Critical evaluation of plasma and LDL oxidant-trapping potential in hemodialysis patients
92. Expanded CD14 + CD16 + monocyte subpopulation in patients with acute and chronic infections undergoing hemodialysis
93. Access problems plague both peritoneal dialysis and hemodialysis
94. Leukocyte sequestration in isolated guinea pig lungs during extracorporeal circulation: Effects on microvascular function
95. The effect of uremia on tumor necrosis factor-alpha release after an in vitro whole-blood endotoxin challenge
96. Reduction of neutrophil activation by vitamin E modified dialyzer membranes
97. Impaired lymphocyte calcium metabolism in end-stage renal disease: Enhanced influx, decreased efflux, and reduced response to mitogen
98. Antibody responses to influenza vaccination in patients with chronic renal failure
99. Increased incidence of postoperative infections associated with peritoneal dialysis in renal transplant recipients
100. Iron and infection
101. Characteristics of long-term renal transplant survivors
102. Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells
103. Neoplasms in dialysis patients: A population-based study
104. Dissociation between complement activation, integrin expression and neutropenia during hemodialysis
105. Pneumococcal vaccine immunization of patients with renal impairment
106. Mortality caused by sepsis in patients with end-stage renal disease compared with the general population
107. The neutrophil as a cellular source of chemokines
108. Hematologic aspects of renal insufficiency
109. Response to measles-mumps-rubella vaccine in children on dialysis
110. Soluble CD40 in the serum of healthy donors, patients with chronic renal failure, haemodialysis and chronic ambulatory peritoneal dialysis (CAPD) patients
111. Treatment with recombinant human erythropoietin increases antibody titers after hepatitis B vaccination in dialysis patients
112. Factors influencing response to hepatitis B virus vaccination in hemodialysis patients
113. Impaired oxidative metabolism by leukocytes from renal transplant recipients: A potential mechanism for the increased susceptibility to infection
114. Lack of enhanced T-helper cell function in uremic patients with circulating alloreactive antibodies
115. Good seroresponse to enhanced-potency inactivated poliovirus vaccine in patients on chronic dialysis
116. Leukocyte adhesion molecules and leukocyte-platelet interactions during hemodialysis: Effects of different synthetic membranes
117. Biocompatibility and functional performance of a polyethylene glycol acid-grafted cellulosic membrane for hemodialysis
118. Changes in neutrophil surface phenotype during hemodialysis
119. Tuberculin and anergy skin testing of patients receiving long-term hemodialysis
120. Influenza antibody titers after vaccination of chronic renal failure patients; before and during hemodialysis, or on continuous ambulatory peritoneal dialysis
121. Dialysis neutropenia: The role of the cytoskeleton
122. Tuberculous peritonitis in patients undergoing continuous ambulatory peritoneal dialysis: Case report and review
123. 8-Hydroxy-2′-deoxyguanosine of leukocyte DNA as a marker of oxidative stress in chronic hemodialysis patients
124. Calcitriol therapy modulates the cellular immune responses in hemodialysis patients
125. Effects of zinc supplementation on the immune system and on antibody response to multivalent influenza vaccine in hemodialysis patients
126. Immune response in hemodialysis patients: Is there any difference when low and high iPTH levels are compared?
127. Analogs of 1,25-dihydroxyvitamin D3 as dose-reducing agents for classical immunosuppressants
128. TNF-alpha: mRNA, plasma protein levels and soluble receptors in patients on chronic hemodialysis, on CAPD and with end-stage renal failure
129. Polymorphonuclear cell function and infection in dialysis
130. Infectious morbidity and defects of phagocytic function in end-stage renal disease: A review
131. Relationship between biocompatibility and neutrophil function in hemodialysis patients
132. Anergic T cells inhibit the antigen-presenting function of dendritic cells
133. Intact humoral immune response in patients on continuous ambulatory peritoneal dialysis
134. Complete success of intradermal vaccination against hepatitis B in advanced chronic renal failure and hemodialysis patients
135. Successful vaccination with intradermal hepatitis B vaccine in hemodialysis patients previously nonresponsive to intramuscular hepatitis B vaccine
136. Iron, anemia, and infection
137. Hemodialysis with cellulose membranes primes the neutrophil oxidative burst
138. The effects of malnutrition on secretory and cellular immune processes
139. Immunisation against varicella in end stage and pre-end stage renal failure
140. Nutritional immunity. Host's attempt to withhold iron from microbial invaders
141. Diminished adhesion of CD4+ T cells from dialysis patients to extracellular matrix and its components fibronectin and laminin
142. Complications from permanent hemodialysis vascular access